7.99% volatility in Adaptive Biotechnologies Corp (ADPT) last month: This is a red flag warning

A new trading day began on Friday, with Adaptive Biotechnologies Corp (NASDAQ: ADPT) stock price up 7.32% from the previous day of trading, before settling in for the closing price of $4.37. ADPT’s price has ranged from $2.28 to $6.70 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

A company in the Healthcare sector has jumped its sales by 27.46% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 28.53%. With a float of $142.73 million, this company’s outstanding shares have now reached $145.08 million.

In an organization with 709 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 53.84%, operating margin of -93.9%, and the pretax margin is -110.17%.

Adaptive Biotechnologies Corp (ADPT) Insider Updates

As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Adaptive Biotechnologies Corp is 3.29%, while institutional ownership is 92.16%. The most recent insider transaction that took place on Nov 18 ’24, was worth 1,235. In this transaction Chief Financial Officer of this company sold 248 shares at a rate of $4.98, taking the stock ownership to the 154,330 shares. Before that another transaction happened on Aug 22 ’24, when Company’s SVP and General Counsel sold 26,922 for $4.50, making the entire transaction worth $121,079. This insider now owns 139,365 shares in total.

Adaptive Biotechnologies Corp (ADPT) Performance Highlights and Predictions

According to the Wall Street analysts, stocks earnings will be around 28.53% per share during the next fiscal year.

Adaptive Biotechnologies Corp (NASDAQ: ADPT) Trading Performance Indicators

Here are Adaptive Biotechnologies Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.38. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.19.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.34, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -0.93 in one year’s time.

Technical Analysis of Adaptive Biotechnologies Corp (ADPT)

Let’s dig in a bit further. During the last 5-days, its volume was 1.77 million. That was better than the volume of 1.41 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 8.94%. Additionally, its Average True Range was 0.40.

During the past 100 days, Adaptive Biotechnologies Corp’s (ADPT) raw stochastic average was set at 40.36%, which indicates a significant increase from 17.28% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 94.90% in the past 14 days, which was higher than the 77.77% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $4.96, while its 200-day Moving Average is $4.00. However, in the short run, Adaptive Biotechnologies Corp’s stock first resistance to watch stands at $4.83. Second resistance stands at $4.97. The third major resistance level sits at $5.24. If the price goes on to break the first support level at $4.42, it is likely to go to the next support level at $4.15. Assuming the price breaks the second support level, the third support level stands at $4.01.

Adaptive Biotechnologies Corp (NASDAQ: ADPT) Key Stats

With a market capitalization of 742.83 million, the company has a total of 147,579K Shares Outstanding. Currently, annual sales are 170,280 K while annual income is -225,250 K. The company’s previous quarter sales were 46,440 K while its latest quarter income was -32,070 K.